Biorestorative Therapies Inc Stock Forecast, Predictions & Price Target

Analyst price target for BRTX

Based on 1 analyst offering 12 month price targets for Biorestorative Therapies Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell BRTX stock?

Based on 1 analyst offering ratings for Biorestorative Therapies Inc.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BRTX stock forecasts and price targets.

BRTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Roth Capital
Bottom 11%
Strong BuyInitiates Coverage On$15.00+175.23%2022-12-07

1 of 1

BRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BRTX$5.45$15.00+175.23%Strong Buy
TPST$1.85$18.33+890.97%Strong Buy
VYNE$6.60$18.50+180.30%Strong Buy

Biorestorative Therapies Stock Forecast FAQ

Is Biorestorative Therapies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BRTX) stock is to Strong Buy BRTX stock.

Out of 1 analyst, 1 (100%) are recommending BRTX as a Strong Buy, 0 (0%) are recommending BRTX as a Buy, 0 (0%) are recommending BRTX as a Hold, 0 (0%) are recommending BRTX as a Sell, and 0 (0%) are recommending BRTX as a Strong Sell.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What is BRTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BRTX price target, the average BRTX price target is $15.00, with the highest BRTX stock price forecast at $15.00 and the lowest BRTX stock price forecast at $15.00.

The Wall Street analyst predicted that Biorestorative Therapies's share price could reach $15.00 by Dec 7, 2023. The average Biorestorative Therapies stock price prediction forecasts a potential upside of 175.23% from the current BRTX share price of $5.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.